Clinical trial
A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma
NCT00739297 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma
- Lead sponsor
- Organon and Co
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- December 31, 2008
- Enrollment
- 68 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic asthma